1. Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, et al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn 2010;29:213-40. PMID:
20025020
2. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010;29:4-20. PMID:
19941278
3. Kelleher CJ, Cardozo LD, Toozs-Hobson PM. Quality of life and urinary incontinence. Curr Opin Obstet Gynecol 1995;7:404-8. PMID:
8541463
4. Liberman JN, Hunt TL, Stewart WF, Wein A, Zhou Z, Herzog AR, et al. Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey. Urology 2001;57:1044-50. PMID:
11377301
5. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003;20:327-36. PMID:
12811491
6. Chiaffarino F, Parazzini F, Lavezzari M, Giambanco V; Gruppo Interdisciplinare di Studio Incontinenza Urinaria (GISIU). Impact of urinary incontinence and overactive bladder on quality of life. Eur Urol 2003;43:535-8. PMID:
12705999
7. Vrijens D, Drossaerts J, van Koeveringe G, Van Kerrebroeck P, van Os J, Leue C. Affective symptoms and the overactive bladder - a systematic review. J Psychosom Res 2015;78:95-108. PMID:
25499886
8. Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA 1989;262:914-9. PMID:
2754791
9. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12. PMID:
8721797
10. Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014.
11. Hulley SB, Cummings ST, Browner WS, Grady DG, Newman TB. Outlining clinical research. 4th ed. Artmed: Porto Alegre; 2015.
12. Nicolson P, Kopp Z, Chapple CR, Kelleher C. It’s just the worry about not being able to control it! A qualitative study of living with overactive bladder. Br J Health Psychol 2008;13(Pt 2):343-59. PMID:
17535499
13. Milsom I, Kaplan SA, Coyne KS, Sexton CC, Kopp ZS. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology 2012;80:90-6. PMID:
22748867
14. Sexton CC, Coyne KS, Thompson C, Bavendam T, Chen CI, Markland A. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study. J Am Geriatr Soc 2011;59:1465-70. PMID:
21718275
15. Ikeda Y, Nakagawa H, Ohmori-Matsuda K, Hozawa A, Masamune Y, Nishino Y, et al. Risk factors for overactive bladder in the elderly population: a community-based study with face-to-face interview. Int J Urol 2011;18:212-8. PMID:
21198945
16. Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 2008;101:1388-95. PMID:
18454794
17. Irwin DE, Milsom I, Kopp Z, Abrams P, Cardozo L. Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int 2006;97:96-100. PMID:
16336336
18. Teloken C, Caraver F, Weber FA, Teloken PE, Moraes JF, Sogari PR, et al. Overactive bladder: prevalence and implications in Brazil. Eur Urol 2006;49:1087-92. PMID:
16497431
19. Lim JR, Bak CW, Lee JB. Comparison of anxiety between patients with mixed incontinence and those with stress urinary incontinence. Scand J Urol Nephrol 2007;41:403-6. PMID:
17853035
21. Coyne KS, Sexton CC, Kopp ZS, Ebel-Bitoun C, Milsom I, Chapple C. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS. BJU Int 2011;108:1459-71. PMID:
21371240
22. Ustün TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004;184:386-92. PMID:
15123501
23. Ponde MP. Anxious and depressive symptoms and their correlation with pain severity in patients with peripheral neuropathy. Rev. Psiquiatr Rio Gd Sul 2009;31:24-31.
24. Engel WJ. Uropsychiatry. J Mich State Med Soc 1964;63:273-7. PMID:
14139585
25. Cortes E, Sahai A, Pontari M, Kelleher C. The psychology of LUTS: ICI-RS 2011. Neurourol Urodyn 2012;31:340-3. PMID:
22415717
26. Hirayama A, Torimoto K, Mastusita C, Okamoto N, Morikawa M, Tanaka N, et al. Risk factors for new-onset overactive bladder in older subjects: results of the Fujiwara-kyo study. Urology 2012;80:71-6. PMID:
22626577
27. Bodden-Heidrich R, Beckmann MW, Libera B, Rechenberger I, Bender HG. Psychosomatic aspects of urinary incontinence. Arch Gynecol Obstet 1999;262:151-8. PMID:
10326634